Dr. Olivier Litzka has resigned from the Board, effective June 13, 2024
Dr. Olivier Litzka has resigned from the Board, effective June 13, 2024
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
BMH Staff Writer
Disclaimer: AI-Generated Content
This article was primarily generated using artificial intelligence technology and has undergone only light editing and fact-checking by a human journalist. While we strive for accuracy, please be aware that AI-generated content may contain errors or inconsistencies. Source material for this article came from one of our media partners: Business Wire, GlobeNewswire, or PR Newswire.
Subscribe
